Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-03-30

AUTHORS

Jung-Jun Min, June-Key Chung, Yong Lee, Jae Jeong, Dong Lee, Ja Jang, Myung Lee, Bo Cho

ABSTRACT

. The sodium/iodide symporter (NIS) is known to be responsible for the active accumulation of iodide within the thyroid gland. We evaluated the relationship between the expression of NIS in primary or lymph node lesions and iodine-131 uptake in recurrent lesions of differentiated thyroid cancer. In 67 patients with differentiated thyroid cancer (5 follicular and 62 papillary carcinomas), the expression of NIS was analysed by immunohistochemical staining using polyclonal antibodies against human NIS. We used paraffin block tissues of primary tumours or metastatic lesions, and also assessed 131I uptake in recurrent lesions of thyroid cancer on postoperative 131I whole-body scan. Immunohistochemical staining was positive in 22 patients (32.8%), including 2 of 5 follicular and 20 of 62 papillary carcinomas. Recurrence was confirmed in 40 patients pathologically or clinically by serum thyroglobulin, 131I scan, fluorine-18 fluorodeoxyglucose positron emission tomography and/or computed tomography. Among these 40 patients, 28 showed positive uptake on 131I scan. Fourteen tumour specimens out of 28 (50%) were positive by NIS immunohistochemical staining. The remaining 12 patients with recurrent cancer showed negative 131I scans, and all specimens were negative by NIS immunohistochemical staining. Thus, NIS immunohistochemical staining predicted 131I uptake in recurrent cancer with a 100% positive predictive value and a 46.2% negative predictive value. There was no difference in the positivity of NIS according to the site of recurrence on 131I scan. Outcome of 131I therapy could be assessed in 22 of the 28 patients who showed 131I uptake in recurrent lesions. Patients with positive NIS immunostaining responded to 131I therapy better than did patients with negative immunostaining (P<0.05). In conclusion, NIS immunohistochemical staining showed a high positive predictive value in predicting iodine uptake. Positive immunohistochemical staining of human NIS in primary or lymph node lesions may predict 131I accumulation and effectiveness of 131I therapy in recurrent lesions. More... »

PAGES

639-645

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002590100509

DOI

http://dx.doi.org/10.1007/s002590100509

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045681756

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24633540


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Min", 
        "givenName": "Jung-Jun", 
        "id": "sg:person.01151675543.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151675543.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "June-Key", 
        "id": "sg:person.0751347234.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Yong", 
        "id": "sg:person.0724572466.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724572466.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeong", 
        "givenName": "Jae", 
        "id": "sg:person.01301360400.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong", 
        "id": "sg:person.014226325120.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014226325120.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Seoul National University College of Medicine, Seoul, Korea, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Pathology, Seoul National University College of Medicine, Seoul, Korea, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jang", 
        "givenName": "Ja", 
        "id": "sg:person.01102152417.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102152417.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110\u2013744, Korea, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Myung", 
        "id": "sg:person.016004105522.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016004105522.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cho", 
        "givenName": "Bo", 
        "id": "sg:person.010765411662.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010765411662.09"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/379458a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016268461", 
          "https://doi.org/10.1038/379458a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-03-30", 
    "datePublishedReg": "2001-03-30", 
    "description": "Abstract. The sodium/iodide symporter (NIS) is known to be responsible for the active accumulation of iodide within the thyroid gland. We evaluated the relationship between the expression of NIS in primary or lymph node lesions and iodine-131 uptake in recurrent lesions of differentiated thyroid cancer. In 67 patients with differentiated thyroid cancer (5 follicular and 62 papillary carcinomas), the expression of NIS was analysed by immunohistochemical staining using polyclonal antibodies against human NIS. We used paraffin block tissues of primary tumours or metastatic lesions, and also assessed 131I uptake in recurrent lesions of thyroid cancer on postoperative 131I whole-body scan. Immunohistochemical staining was positive in 22 patients (32.8%), including 2 of 5 follicular and 20 of 62 papillary carcinomas. Recurrence was confirmed in 40 patients pathologically or clinically by serum thyroglobulin, 131I scan, fluorine-18 fluorodeoxyglucose positron emission tomography and/or computed tomography. Among these 40 patients, 28 showed positive uptake on 131I scan. Fourteen tumour specimens out of 28 (50%) were positive by NIS immunohistochemical staining. The remaining 12 patients with recurrent cancer showed negative 131I scans, and all specimens were negative by NIS immunohistochemical staining. Thus, NIS immunohistochemical staining predicted 131I uptake in recurrent cancer with a 100% positive predictive value and a 46.2% negative predictive value. There was no difference in the positivity of NIS according to the site of recurrence on 131I scan. Outcome of 131I therapy could be assessed in 22 of the 28 patients who showed 131I uptake in recurrent lesions. Patients with positive NIS immunostaining responded to 131I therapy better than did patients with negative immunostaining (P<0.05). In conclusion, NIS immunohistochemical staining showed a high positive predictive value in predicting iodine uptake. Positive immunohistochemical staining of human NIS in primary or lymph node lesions may predict 131I accumulation and effectiveness of 131I therapy in recurrent lesions.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002590100509", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "keywords": [
      "differentiated thyroid cancer", 
      "lymph node lesions", 
      "recurrent lesions", 
      "immunohistochemical staining", 
      "expression of NIS", 
      "positive predictive value", 
      "thyroid cancer", 
      "sodium/iodide symporter", 
      "predictive value", 
      "recurrent cancer", 
      "node lesions", 
      "fluorine-18 fluorodeoxyglucose positron emission tomography", 
      "fluorodeoxyglucose positron emission tomography", 
      "site of recurrence", 
      "high positive predictive value", 
      "iodine-131 uptake", 
      "differentiated thyroid carcinoma", 
      "whole-body scan", 
      "positive immunohistochemical staining", 
      "negative predictive value", 
      "positron emission tomography", 
      "paraffin block tissue", 
      "metastatic lesions", 
      "serum thyroglobulin", 
      "primary tumor", 
      "papillary carcinoma", 
      "thyroid carcinoma", 
      "positive uptake", 
      "negative immunostaining", 
      "patients", 
      "thyroid gland", 
      "iodine uptake", 
      "lesions", 
      "emission tomography", 
      "human NIS", 
      "cancer", 
      "human NIS", 
      "therapy", 
      "staining", 
      "scans", 
      "carcinoma", 
      "recurrence", 
      "tumors", 
      "immunostaining", 
      "polyclonal antibodies", 
      "tomography", 
      "NIS", 
      "uptake", 
      "expression", 
      "active accumulation", 
      "symporter", 
      "antibodies", 
      "thyroglobulin", 
      "positivity", 
      "gland", 
      "outcomes", 
      "tissue", 
      "accumulation", 
      "conclusion", 
      "differences", 
      "relationship", 
      "specimens", 
      "values", 
      "sites", 
      "effectiveness", 
      "iodide", 
      "Ni"
    ], 
    "name": "Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma", 
    "pagination": "639-645", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045681756"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002590100509"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24633540"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002590100509", 
      "https://app.dimensions.ai/details/publication/pub.1045681756"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_328.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002590100509"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002590100509'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002590100509'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002590100509'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002590100509'


 

This table displays all metadata directly associated to this object as RDF triples.

184 TRIPLES      21 PREDICATES      92 URIs      83 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002590100509 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N2588da07a279403ab414b62c9b3d6dcf
4 schema:citation sg:pub.10.1038/379458a0
5 schema:datePublished 2001-03-30
6 schema:datePublishedReg 2001-03-30
7 schema:description Abstract. The sodium/iodide symporter (NIS) is known to be responsible for the active accumulation of iodide within the thyroid gland. We evaluated the relationship between the expression of NIS in primary or lymph node lesions and iodine-131 uptake in recurrent lesions of differentiated thyroid cancer. In 67 patients with differentiated thyroid cancer (5 follicular and 62 papillary carcinomas), the expression of NIS was analysed by immunohistochemical staining using polyclonal antibodies against human NIS. We used paraffin block tissues of primary tumours or metastatic lesions, and also assessed 131I uptake in recurrent lesions of thyroid cancer on postoperative 131I whole-body scan. Immunohistochemical staining was positive in 22 patients (32.8%), including 2 of 5 follicular and 20 of 62 papillary carcinomas. Recurrence was confirmed in 40 patients pathologically or clinically by serum thyroglobulin, 131I scan, fluorine-18 fluorodeoxyglucose positron emission tomography and/or computed tomography. Among these 40 patients, 28 showed positive uptake on 131I scan. Fourteen tumour specimens out of 28 (50%) were positive by NIS immunohistochemical staining. The remaining 12 patients with recurrent cancer showed negative 131I scans, and all specimens were negative by NIS immunohistochemical staining. Thus, NIS immunohistochemical staining predicted 131I uptake in recurrent cancer with a 100% positive predictive value and a 46.2% negative predictive value. There was no difference in the positivity of NIS according to the site of recurrence on 131I scan. Outcome of 131I therapy could be assessed in 22 of the 28 patients who showed 131I uptake in recurrent lesions. Patients with positive NIS immunostaining responded to 131I therapy better than did patients with negative immunostaining (P<0.05). In conclusion, NIS immunohistochemical staining showed a high positive predictive value in predicting iodine uptake. Positive immunohistochemical staining of human NIS in primary or lymph node lesions may predict 131I accumulation and effectiveness of 131I therapy in recurrent lesions.
8 schema:genre article
9 schema:isAccessibleForFree false
10 schema:isPartOf N38a08fea98454e54b42f4606c6445fea
11 N67fa7635d18444b589a4504b2b418bde
12 sg:journal.1297401
13 schema:keywords NIS
14 Ni
15 accumulation
16 active accumulation
17 antibodies
18 cancer
19 carcinoma
20 conclusion
21 differences
22 differentiated thyroid cancer
23 differentiated thyroid carcinoma
24 effectiveness
25 emission tomography
26 expression
27 expression of NIS
28 fluorine-18 fluorodeoxyglucose positron emission tomography
29 fluorodeoxyglucose positron emission tomography
30 gland
31 high positive predictive value
32 human NIS
33 immunohistochemical staining
34 immunostaining
35 iodide
36 iodine uptake
37 iodine-131 uptake
38 lesions
39 lymph node lesions
40 metastatic lesions
41 negative immunostaining
42 negative predictive value
43 node lesions
44 outcomes
45 papillary carcinoma
46 paraffin block tissue
47 patients
48 polyclonal antibodies
49 positive immunohistochemical staining
50 positive predictive value
51 positive uptake
52 positivity
53 positron emission tomography
54 predictive value
55 primary tumor
56 recurrence
57 recurrent cancer
58 recurrent lesions
59 relationship
60 scans
61 serum thyroglobulin
62 site of recurrence
63 sites
64 sodium/iodide symporter
65 specimens
66 staining
67 symporter
68 therapy
69 thyroglobulin
70 thyroid cancer
71 thyroid carcinoma
72 thyroid gland
73 tissue
74 tomography
75 tumors
76 uptake
77 values
78 whole-body scan
79 schema:name Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma
80 schema:pagination 639-645
81 schema:productId N02387f012ed0472d91af5b21a184a703
82 Ne3dc57d107db4ee8a8e10229096e5240
83 Ne848855f397d4532b81de001a8a2a2e6
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045681756
85 https://doi.org/10.1007/s002590100509
86 schema:sdDatePublished 2022-11-24T20:49
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher Ne8217d57280649ceaa6465bb6c5b3af1
89 schema:url https://doi.org/10.1007/s002590100509
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N02387f012ed0472d91af5b21a184a703 schema:name pubmed_id
94 schema:value 24633540
95 rdf:type schema:PropertyValue
96 N2588da07a279403ab414b62c9b3d6dcf rdf:first sg:person.01151675543.91
97 rdf:rest N9b467ff7fbba4b63832847b26ce676d1
98 N38a08fea98454e54b42f4606c6445fea schema:volumeNumber 28
99 rdf:type schema:PublicationVolume
100 N395b9e33fe1b405d9ecba3e36d5f6f8c rdf:first sg:person.01301360400.94
101 rdf:rest N45712bb18b87489b8ece7010834fd0e8
102 N45712bb18b87489b8ece7010834fd0e8 rdf:first sg:person.014226325120.78
103 rdf:rest N606ce602b1464295ac2101e0cbc17fdc
104 N606ce602b1464295ac2101e0cbc17fdc rdf:first sg:person.01102152417.00
105 rdf:rest N9e0177a8ef0e4248a9fd7792a926e82e
106 N67fa7635d18444b589a4504b2b418bde schema:issueNumber 5
107 rdf:type schema:PublicationIssue
108 N9b467ff7fbba4b63832847b26ce676d1 rdf:first sg:person.0751347234.39
109 rdf:rest Nc3b781d257ed4e5985b2e6d31bc44d5a
110 N9e0177a8ef0e4248a9fd7792a926e82e rdf:first sg:person.016004105522.16
111 rdf:rest Nd393610729694fe0a9d7ffcd5e353105
112 Nc3b781d257ed4e5985b2e6d31bc44d5a rdf:first sg:person.0724572466.08
113 rdf:rest N395b9e33fe1b405d9ecba3e36d5f6f8c
114 Nd393610729694fe0a9d7ffcd5e353105 rdf:first sg:person.010765411662.09
115 rdf:rest rdf:nil
116 Ne3dc57d107db4ee8a8e10229096e5240 schema:name doi
117 schema:value 10.1007/s002590100509
118 rdf:type schema:PropertyValue
119 Ne8217d57280649ceaa6465bb6c5b3af1 schema:name Springer Nature - SN SciGraph project
120 rdf:type schema:Organization
121 Ne848855f397d4532b81de001a8a2a2e6 schema:name dimensions_id
122 schema:value pub.1045681756
123 rdf:type schema:PropertyValue
124 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
125 schema:name Medical and Health Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
128 schema:name Oncology and Carcinogenesis
129 rdf:type schema:DefinedTerm
130 sg:journal.1297401 schema:issn 1619-7070
131 1619-7089
132 schema:name European Journal of Nuclear Medicine and Molecular Imaging
133 schema:publisher Springer Nature
134 rdf:type schema:Periodical
135 sg:person.010765411662.09 schema:affiliation grid-institutes:grid.31501.36
136 schema:familyName Cho
137 schema:givenName Bo
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010765411662.09
139 rdf:type schema:Person
140 sg:person.01102152417.00 schema:affiliation grid-institutes:grid.31501.36
141 schema:familyName Jang
142 schema:givenName Ja
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102152417.00
144 rdf:type schema:Person
145 sg:person.01151675543.91 schema:affiliation grid-institutes:grid.31501.36
146 schema:familyName Min
147 schema:givenName Jung-Jun
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151675543.91
149 rdf:type schema:Person
150 sg:person.01301360400.94 schema:affiliation grid-institutes:grid.31501.36
151 schema:familyName Jeong
152 schema:givenName Jae
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94
154 rdf:type schema:Person
155 sg:person.014226325120.78 schema:affiliation grid-institutes:grid.31501.36
156 schema:familyName Lee
157 schema:givenName Dong
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014226325120.78
159 rdf:type schema:Person
160 sg:person.016004105522.16 schema:affiliation grid-institutes:grid.31501.36
161 schema:familyName Lee
162 schema:givenName Myung
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016004105522.16
164 rdf:type schema:Person
165 sg:person.0724572466.08 schema:affiliation grid-institutes:grid.31501.36
166 schema:familyName Lee
167 schema:givenName Yong
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724572466.08
169 rdf:type schema:Person
170 sg:person.0751347234.39 schema:affiliation grid-institutes:grid.31501.36
171 schema:familyName Chung
172 schema:givenName June-Key
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39
174 rdf:type schema:Person
175 sg:pub.10.1038/379458a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016268461
176 https://doi.org/10.1038/379458a0
177 rdf:type schema:CreativeWork
178 grid-institutes:grid.31501.36 schema:alternateName Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Korea
179 Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110–744, Korea, Korea
180 Department of Pathology, Seoul National University College of Medicine, Seoul, Korea, Korea
181 schema:name Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Korea
182 Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, Chongno-gu, Seoul 110–744, Korea, Korea
183 Department of Pathology, Seoul National University College of Medicine, Seoul, Korea, Korea
184 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...